Table 6 Comparison between each pair of the groups.

From: The impact of time length to Boolean remission for tight disease activity control after acquisition in rheumatoid arthritis patients

 

Group1

Group2

Group3

p-value

1 vs 2

1 vs 3

2 vs 3

TL (months)

3.7 (3.0–4.3)

5.8 (4.8–6.9)

16.1 (12.7–19.5)

0.32

< 0.001

< 0.001

SDAI

1.84 (1.62–2.06)

3.92 (3.65–4.20)

6.91 (6.45–7.38)

< 0.001

< 0.001

< 0.001

HAQ-DI

0.251 (0.187–0.315)

0.372 (0.296–0.447)

0.644 (0.532–0.755)

0.13

< 0.001

< 0.001

PS-VAS

10.2 (8.8–11.6)

23.5 (21.3–25.7)

33.8 (31.2–36.3)

< 0.001

< 0.001

< 0.001

SHS

32.3 (25.9–38.7)

43.3 (34.1–52.5)

68.0 (54.1–81.9)

< 0.001

< 0.001

< 0.001

QOLS

0.876 (0.860–0.892)

0.848 (0.833–0.863)

0.773 (0.750–0.795)

< 0.001

< 0.001

< 0.001

  1. Statistical procedures: Student T-test.
  2. In columns, mean value and 95% confidence interval in parentheses are shown.
  3. Statistical procedure: Student T-test.
  4. Columns show initial mean, 95% confidence interval in parentheses.
  5. All parameters are calculated as means.
  6. TL time from baseline to first Boolean remission, SDAI simplified disease activity index score, HAQ-DI Health Assessment Questionnaire Disability Index score, PS-VAS pain score using visual analog scale, SHS Sharp/van der Heijde score, QOLS quality of life score calculated from EuroQol 5th-dimension score.
Back to article page